← Back to Search

Dietary Supplement

LLP-01 for Inflammation in Healthy, Older Individuals

N/A

Waitlist Available

Led By Adi Ramon, M.Sc

Research Sponsored by LL Prosper Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up change from baseline to 60 days and compared to placebo

Awards & highlights

Study Summary

This trial studies if a plant-based solution can reduce inflammation and reverse signs of aging.

Who is the study for?

This trial is for healthy individuals aged 50-75 who can take pills, follow the treatment plan, and provide blood samples. They must not be on any medication or have taken certain supplements recently. People with medical diseases, on anticoagulants, substance addiction, recent participation in another trial or those unable to consent are excluded.Check my eligibility

What is being tested?

The study tests if a botanical formulation called LLP-01 affects inflammation markers and epigenetic age compared to a placebo. It's designed for up to 40 participants who will be randomly assigned to receive either LLP-01 or a dummy pill without knowing which one they're getting.See study design

What are the potential side effects?

Since this is a botanical product being tested in healthy individuals, specific side effects aren't listed but may include allergic reactions or sensitivities related to the ingredients of LLP-01.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ change from baseline to 60 days and compared to placebo

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~change from baseline to 60 days and compared to placebo

This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to 60 days and compared to placebo for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Plasma Proteomic Changes

Secondary outcome measures

Epigenetic Age

Grip Strength

Weight/BMI

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: Experimental GroupExperimental Treatment1 Intervention

Participants in this arm will receive a herbal capsule formulation, called LLP-01, consisting of 2 capsules taken once daily without food for 60 days. The capsules contain extracts from naturally occurring plant species, including Withania somnifera, Rosmarinus officinalis, Curcuma longa, Cotinus coggygria, Panax ginseng, Cordyceps militaris, Camellia sinensis, Cotinus coggygria, and Piper nigrum.

Group II: Placebo GroupPlacebo Group1 Intervention

Participants in this arm will receive Placebo capsules, which are visually identical to the capsules in the Experimental Group. These placebo capsules are filled with rice flour and a minor amount of Curcuma longa powder and should be taken in the same manner as the Experimental Group, with 2 capsules taken once daily without food for 60 days.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

LLP-01

2023

N/A

~40

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

LL Prosper Inc.Lead Sponsor

Adi Ramon, M.ScPrincipal InvestigatorChief Compliance Officer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Would I meet the requirements to join this experimental research?

"To qualify for this trial, potential participants must be aged between 50 and 75 and have recorded evidence of inflammation. This clinical study seeks to recruit 40 patients in total."

Answered by AI

Does this clinical trial accept participants below the age of 35?

"The age range for participants in this clinical trial is between 50 and 75 years old. Furthermore, there are 35 studies available for those younger than 18 and 491 trials open to individuals older than 65."

Answered by AI

Is enrollment into this medical trial still available to the public?

"Data gleaned from clinicaltrials.gov confirms that this medical trial, initially posted on September 27th 2023, is actively recruiting participants. The information was last revised a day prior to the current date."

Answered by AI

How many individuals have taken part in this clinical experiment thus far?

"Affirmative. Clinicaltrials.gov data shows that this clinical trial is currently recruiting, having been initially posted on September 27th 2023 and last updated the following day. 40 patients are being recruited to participate at a single location."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals.

2023. "Quantifiably Determine if the Botanical Formulation, LLP-01, Has a Significant Clinical Effect on Proteomic Inflammatory Biomarkers and Epigenetic Changes in Healthy, Older Individuals.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06065241.